Anzeige
Mehr »
Login
Montag, 31.03.2025 Börsentäglich über 12.000 News von 695 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QEF3 | ISIN: CA98980M1095 | Ticker-Symbol:
NASDAQ
04.03.25
22:00 Uhr
0,095 US-Dollar
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ZOMEDICA CORP Chart 1 Jahr
5-Tage-Chart
ZOMEDICA CORP 5-Tage-Chart

Aktuelle News zur ZOMEDICA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
18.03.Zomedica-Direktor Christopher MacLeod kauft Aktien im Wert von 8.437 US-Dollar-
ZOMEDICA Aktie jetzt für 0€ handeln
18.03.Zomedica-Direktor Christopher MacLeod erwirbt Aktien im Wert von 8.437 US-Dollar-
18.03.Zomedica-Vizepräsident kauft Stammaktien im Wert von 48.998 US-Dollar1
18.03.Zomedica COO Blair Anthony K erwirbt Stammaktien im Wert von 30.000 US-Dollar1
18.03.Zomedica-Direktor Williams erwirbt Stammaktien im Wert von 6.900 US-Dollar1
13.03.Zomedica Corp.: Zomedica Reports Record Revenue of $7.9 Million for the Fourth Quarter and $27.3 Million for the Full Year 2024; 70% Gross Margin, and $71 Million in Liquidity to Support Growth280ANN ARBOR, MI / ACCESS Newswire / March 13, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products...
► Artikel lesen
13.03.Zomedica Corp. - 10-K, Annual Report3
13.03.NSE - Zomedica Corp. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities3
05.03.Zomedica Corp. - 8-K, Current Report1
04.03.Zomedica Corp. Announces Transition to OTCQB Venture Market351Zomedica's ticker symbol will change to ZOMDF ANN ARBOR, MI / ACCESS Newswire / March 4, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a leading veterinary health company...
► Artikel lesen
04.03.NYSE American to Commence Delisting Proceedings Against Zomedica Corp. (ZOM)89NEW YORK--(BUSINESS WIRE)--NYSE American LLC ("NYSE American" or the "Exchange") announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common shares...
► Artikel lesen
26.02.Zomedica Corp.: Zomedica to Report Fourth Quarter and Full Year 2024 Financial Results with a Business Update on March 13th at 4:30 p.m. ET264ANN ARBOR, MI / ACCESS Newswire / February 26, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic...
► Artikel lesen
12.02.Zomedica Corp.: Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters277Relocation to More Efficient Space Supports Growth While Reducing Overhead by Over $200,000 Annually ANN ARBOR, MI / ACCESS Newswire / February 12, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica"...
► Artikel lesen
06.02.Zomedica Corp.: Zomedica Launches the TRUFORMA Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis325Zomedica continues to redefine what is possible in point of care diagnostics with the TRUFORMA biosensor platform ANN ARBOR, MI / ACCESS Newswire / February 6, 2025 / Zomedica Corp. (NYSE American:ZOM)...
► Artikel lesen
07.01.Zomedica Corp.: Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel Hemostatic Gel in the Animal Health Market559License Agreement Expands Zomedica's Portfolio with Revolutionary Hemostatic Technology ANN ARBOR, MI / ACCESSWIRE / January 7, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company")...
► Artikel lesen
23.12.24Zomedica Unveils New Canine Tests Offering Faster Diagnostics for Heart and Breeding Health10
23.12.24Zomedica Corp.: Zomedica Launches Two New Quantitative Assays on the TRUFORMA Platform: Canine NT-proBNP and Progesterone288With the addition of these two new assay launches, Zomedica has added 8 new assays in the past 18 months to the rapidly growing TRUFORMA Platform ANN ARBOR, MI / ACCESSWIRE / December 23, 2024 / Zomedica...
► Artikel lesen
19.12.24Zomedica Corp. - 8-K, Current Report3
19.12.24Zomedica appoints Scott Jordan as EVP, finance & CFO5
19.12.24Zomedica Corp.: Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer368Seasoned executive brings a broad skill set to Zomedica's leadership team ANN ARBOR, MI / ACCESSWIRE / December 19, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary...
► Artikel lesen
Seite:  Weiter >>
63 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1